Tue, March 17, 2026

Wellness CGMs Gain Traction Beyond Diabetes Management

The Rise of the 'Wellness CGM'

Traditionally, CGMs worked by measuring glucose levels in interstitial fluid--the fluid surrounding cells just under the skin--providing readings every few minutes. This constant stream of data allowed for precise insulin adjustments and a clearer picture of glycemic control. But the benefits aren't limited to those with diabetes. A growing number of individuals without diabetes are adopting CGMs to gain insights into how their diet, exercise, sleep, and stress levels impact their glucose levels. This practice, often termed 'biohacking' or 'metabolic tracking,' seeks to optimize energy levels, improve cognitive function, and enhance overall well-being.

This burgeoning interest has created a demand for CGMs that are more discreet, user-friendly, and geared towards preventative health rather than solely disease management. Lingo and Stelo are responding to this demand with designs and features tailored to a wider audience.

Lingo: Connecting Glucose Data to Personalized Healthcare

Developed by Levels Health, a company already recognized for its metabolic health platform, Lingo takes a sophisticated approach to CGM technology. A key differentiator is its emphasis on integrating glucose data with healthcare professionals. While requiring a prescription, this allows users to actively share their glucose trends with doctors, nutritionists, or other providers, fostering a more collaborative and informed approach to health management.

The Lingo CGM prioritizes a sleek, minimalist design, aiming to be as unobtrusive as possible under clothing. However, this level of functionality and integration comes at a price, making it one of the more expensive options on the market. Its sensors currently have a lifespan of 14 days. While offering valuable raw data, some users may find its built-in data analytics less comprehensive than Levels Health's full platform.

Stelo: Democratizing Glucose Monitoring with Affordability and Privacy

Stelo is shaking up the CGM space with a distinctly different philosophy: accessibility. As the first CGM available without a prescription, Stelo removes a significant barrier to entry for those curious about glucose tracking. Furthermore, it operates independently of a recurring subscription, lowering the overall cost of ownership.

Stelo's focus extends to data privacy, emphasizing user control over their information. The device and accompanying app are designed for simplicity and ease of use, making it an appealing choice for beginners. However, this simplicity comes with trade-offs. Stelo's sensors have a shorter lifespan of only 7 days, requiring more frequent replacements. The device itself is slightly bulkier than the Lingo, and its app features are currently more basic.

Lingo vs. Stelo: A Head-to-Head Comparison

The choice between Lingo and Stelo ultimately depends on individual needs and priorities. Here's a closer look at the key differences:

FeatureLingoStelo
Prescription RequiredYesNo
CostHigherLower
Sensor Life14 days7 days
DesignSleek, MinimalistSlightly Bulky
Data SharingHealthcare Professional IntegrationUser-Controlled
Data PrivacyStandardPrioritized
SubscriptionRequiredNot Required

The Future of Glucose Monitoring

The emergence of Lingo and Stelo signals a broader trend: the democratization of health data. These devices are empowering individuals to take a more active role in understanding their bodies and optimizing their well-being. While CGMs were once primarily tools for disease management, they are now becoming increasingly valuable for preventative health, performance enhancement, and personalized nutrition. As the technology continues to evolve and become more accessible, we can expect to see even more innovative applications of continuous glucose monitoring in the years to come. The potential to personalize healthcare and empower individuals through data-driven insights is immense, and Lingo and Stelo are at the forefront of this exciting transformation.


Read the Full CNN Article at:
[ https://www.cnn.com/cnn-underscored/reviews/lingo-vs-stelo-continous-glucose-monitors ]